Prevalence rate and risk factors for preeclampsia and eclampsia among pregnant women attending Qena University Hospital During COVID-19 pandemic

Ameen, Rania Abd El Hakeem; Hany, Ahmed M.M.; Ali, AbdelNaser AbdelGaber

doi:10.21608/svuijm.2022.147371.1330

Cited by 4 publications

(5 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the total score, item scores for each subscale are added together, and higher PRHDS subscale scores imply a higher risk perception of developing heart disease [33]. Across subscales, reverse scoring of these items (6,(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20) is required. The PRHDS had previously shown good construct validity, with an overall alpha scale of 0.80.…”

Section: The Perception Of Risk Of Heart Disease Scale (Prhds)mentioning

confidence: 99%

See 1 more Smart Citation

Perceived Cardiovascular Disease Risk Following Preeclampsia: A Cross-Sectional Study

Hussien,

Shuaib,

Baraia

et al. 2023

Healthcare

View full text Add to dashboard Cite

Preeclampsia has been linked to an increased risk of cardiovascular disease (CVD), and the preeclamptic women were unaware of this link. Therefore, this study aims to assess women’s knowledge and perception of future CVD after preeclampsia. This study used a cross-sectional descriptive design. Two hundred and forty-six women with a preeclampsia history were recruited from the Al Salam MCH Center and Suez Canal University Hospital. Data were collected during March 2022 using a socio-demographic questionnaire, an Adapted Coronary Heart disease knowledge tool for preeclamptic women, and The Perception of Risk of Heart Disease Scale (PRHDS). Most women (96%) were unaware of the relationship between CVD and preeclampsia. The women had a low CVD knowledge level (10.26 ± 6.08) as well as a low perception of cardiovascular disease risk (37.15 ± 7.22). There was a significant positive correlation between CVD knowledge and CVD risk perception (r = 0.434, p = 0.000). This study found that preeclampsia survivors underestimated their CVD risk. Based on these findings, preeclamptic women should receive health education sessions on CVD risk and prevention from their nurses and obstetricians. The hospital pre-discharge plan must contain these sessions in written and electronic formats to help women remember and follow CVD risk reduction measures.

show abstract

Section: The Perception Of Risk Of Heart Disease Scale (Prhds)mentioning

confidence: 99%

“…Among Egyptian women, about 6–8% of all pregnancies are complicated by preeclampsia, and this number raises to as high as 15% in tertiary care facilities. Also, preeclampsia is still the primary cause of maternal mortality and represents 27.7% of the avoidable causes of maternal mortality [ 11 , 12 ].…”

Section: Introductionmentioning

confidence: 99%

Perceived Cardiovascular Disease Risk Following Preeclampsia: A Cross-Sectional Study

Hussien,

Shuaib,

Baraia

et al. 2023

Healthcare

View full text Add to dashboard Cite

show abstract

“…The disease is also known as the most common cause of iatrogenic prematurity in developed countries [15]. Preeclampsia, which occurs in 10% of pregnant women, causes 76,000 maternal deaths and 500,000 infant deaths per year worldwide [16]. According to the 2019 National Institute for Health and Care Excellence (NICE) guidelines, women who have a history of hypertension in previous pregnancies or other maternal diseases, such as diabetes, high blood pressure, chronic kidney disease, autoimmune disease, and obesity, are at higher risk of developing preeclampsia.…”

Section: Introductionmentioning

confidence: 99%

Preeclampsia and the Associated Risk Factors Among Pregnant Women in Indonesia: a Literature Review

Ari,

Novembriany,

Norlina

et al. 2024

PoS

View full text Add to dashboard Cite

Nationally, the maternal mortality rate in Indonesia has dropped from 305 deaths per 100,000 live births to 189 deaths for 100,000 living births. The top three causes of maternal death are preeclampsia. Preeclampsia in pregnancy is the leading cause of death of 37%. This study was conducted to determine factors associated with preeclampsia among pregnant women in Indonesia. This scoping review method has the following inclusion criteria: scientific journals published most recently from January 2023 to December 2023. The research found 15 studies to fulfil the inclusion criteria determined by the author and topic discussion. Risk factors for preeclampsia among pregnant women were identified: parity, distance between pregnancies, pregnancy age, history of abortion, education, income, knowledge, prior history of illness, contraceptive use, ANC visit, nutritional status, and Body Mass Index (BMI). This research can be used as a reference for health promotion related to preeclampsia risk factors for intervention to prevent preeclampsia in pregnant women who are at risk of developing the disease and putting the lives of the mother and the fetus she is carrying at risk.

show abstract

“…Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. 1 In Egypt, Ameen et al, 2023 2 reported that preeclampsia and eclampsia complicate about 6%-8% of all pregnancies and can reach up to 15% in referral centers like university hospitals and became increasingly common during the COVID-19 pandemic, with preeclampsia and eclampsia prevalence rates of 19% and 1%, respectively.…”

Section: Introductionmentioning

confidence: 99%

Association between angiotensin converting enzyme gene polymorphism (rs4343) and susceptibility to gestational hypertension and preeclampsia in pregnant women

Kamal

Morsy

Elalim

et al. 2023

EJI

View full text Add to dashboard Cite

Hypertension is the most frequent medical complication of pregnancy, and the most severe clinical presentation of hypertensive disorders of pregnancy (HDP) is preeclampsia (PE). PE is a condition significantly associated with maternal and perinatal morbidity and mortality. The etiology of PE remains unknown. However, it has been found that genetic factors cause a defective immune adaptation, which in turn leads to inadequate trophoblast invasion and inappropriate placenta development. This study involved 30 patients with gestational hypertension (GH), 30 patients with PE and 30 normotensive pregnant women as controls. We aimed to evaluate the association between the angiotensin-converting enzyme (ACE) gene polymorphism (rs4343) and susceptibility to GH and PE. Genotyping for rs4343 polymorphism was performed by real-time polymerase chain reaction. The differences of genotypes and allele frequencies were analyzed as well as the relationship between ACE polymorphism and susceptibility to PE. The GG genotype of ACE gene rs4343 and G allele frequency were significantly associated with increased risk of PE [OR (95% CI) 10.3125 (2.1043 to 50.5388), p=0.004 and OR (95% CI) 3.4714 (1.6352 to 7.3697), p = 0.001, respectively]. Also, G allele frequency was significantly associated with severity of PE [OR (95% CI) 15.5455 (1.8938 to 127.6075), p = 0.011]. However, the GG genotype and G allele frequency were not associated with GH. In conclusion, ACE rs4343 polymorphism may be associated with PE susceptibility and severity but not with GH.

show abstract

Prevalence rate and risk factors for preeclampsia and eclampsia among pregnant women attending Qena University Hospital During COVID-19 pandemic

Cited by 4 publications

References 2 publications

Perceived Cardiovascular Disease Risk Following Preeclampsia: A Cross-Sectional Study

Perceived Cardiovascular Disease Risk Following Preeclampsia: A Cross-Sectional Study

Preeclampsia and the Associated Risk Factors Among Pregnant Women in Indonesia: a Literature Review

Association between angiotensin converting enzyme gene polymorphism (rs4343) and susceptibility to gestational hypertension and preeclampsia in pregnant women

Contact Info

Product

Resources

About